BELOIT, Wis., Jan. 27, 2020 /PRNewswire/ -- Louis Pinkham, Chief Executive Officer of Regal Beloit Corporation (NYSE: RBC), announced that the Board of Directors, at its regular quarterly meeting held on January 25, 2020, declared a dividend of $0.30 per share. The dividend is payable on April 9, 2020, to shareholders of record at the close of business on March 27, 2020. The company has paid a dividend every quarter since January 1961.
Regal Beloit Corporation (NYSE: RBC) is a global leader in the engineering and manufacturing of electric motors and controls, power generation products and power transmission products serving customers throughout the world. We create a better tomorrow by developing and responsibly producing energy-efficient products and systems.
Our company is comprised of three operating segments: Commercial and Industrial Systems, Climate Solutions and Power Transmission Solutions. Regal is headquartered in Beloit, Wisconsin and has manufacturing, sales and service facilities worldwide. For more information, visit RegalBeloit.com.
Paystand, the global leader in blockchain-enabled B2B payments, today announced the acquisition of Teampay, an industry-leading spend management software. The transaction creates a B2B payments powerhouse whose continued goal is to revolutionize...
Magna5, a leading national provider of managed IT, cybersecurity, and cloud-based services, is proud to announce its achievement of three 2024 Top Workplaces awards. These honors are a testament to the company's commitment to fostering an innovative,...
A new research report conducted by Material and NewtonX reveals data and insights into the future of advertising, spotlighting trends in targeting, technology, social media and the impact of AI on marketing. The report, The Digital Lead: 2024...
FinVolution Group ("FinVolution," or the "Company") , a leading fintech platform, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission (the "SEC") on...
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services.
"Mahesh is a dynamic and...
Recon Technology, Ltd. ("Recon" or the "Company") announced today that the Company's shareholders approved on March 29, 2024 to effect a reverse stock split of the Company's Class A ordinary shares at the ratio of one-for-eighteen with the market...
